Fatty Acid Synthase siRNA (h) from Santa Cruz Biotechnology, Inc.

Product Specs
ItemFatty Acid Synthase siRNA (h)
CompanySanta Cruz Biotechnology, Inc.
Price $293.00Supplier Page View Company Product Page
Catalog Numbersc-43758
Gene Namefatty acid synthase
TypesiRNA/dsRNA
NCBI Gene AliasesFAS, OA-519, SDR27X1
NCBI Full Gene Namefatty acid synthase
Specieshuman
Quantity10 µM

Add to Compare List

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) A specific lipid metabolic profile is associated with the epithelial mesenchymal transition programBiochimica et biophysica acta. Molecular and cell biology of lipidsMarch 1, 2019Giudetti AM, De Domenico S, Ragusa A, Lunetti P, Gaballo A, Franck J, Simeone P, Nicolardi G, De Nuccio F, Santino A, et al.

(2) Fatty acid synthase is required for profibrotic TGF-β signalingFASEB journal : official publication of the Federation of American Societies for Experimental BiologyJuly 1, 2018Jung MY, Kang JH, Hernandez DM, Yin X, Andrianifahanana M, Wang Y, Gonzalez-Guerrico A, Limper AH, Lupu R, Leof EB.

(3) FASN regulates cellular response to genotoxic treatments by increasing PARP-1 expression and DNA repair activity via NF-κB and SP1Proceedings of the National Academy of Sciences of the United States of AmericaNovember 8, 2016Wu X, Dong Z, Wang CJ, Barlow LJ, Fako V, Serrano MA, Zou Y, Liu JY, Zhang JT.instructions. For transient transfection of PARP-1 siRNA (Santa Cruz; sc-29437) or FASN siRNA (Santa Cruz; sc-43758), 6 × 105 cells were plated in six-well plates for 24 h, followed by transfection with siRNAs using

(4) Suppression of endogenous lipogenesis induces reversion of the malignant phenotype and normalized differentiation in breast cancerOncotargetNovember 1, 2016Gonzalez-Guerrico AM, Espinoza I, Schroeder B, Park CH, Kvp CM, Khurana A, Corominas-Faja B, Cuyàs E, Alarcón T, Kleer C, et al.

(5) Oridonin induces apoptosis in uveal melanoma cells by upregulation of Bim and downregulation of Fatty Acid SynthaseBiochemical and biophysical research communicationsFebruary 6, 2015Gu Z, Wang X, Qi R, Wei L, Huo Y, Ma Y, Shi L, Chang Y, Li G, Zhou L.

(6) Fatty acid synthase causes drug resistance by inhibiting TNF-α and ceramide productionJournal of lipid researchMarch 1, 2013Liu H, Wu X, Dong Z, Luo Z, Zhao Z, Xu Y, Zhang JT.

(7) Phospho-ΔNp63α/SREBF1 protein interactions: bridging cell metabolism and cisplatin chemoresistanceCell cycle (Georgetown, Tex.)October 15, 2012Huang Y, Bell LN, Okamura J, Kim MS, Mohney RP, Guerrero-Preston R, Ratovitski EA.

(8) New synthetic inhibitors of fatty acid synthase with anticancer activityJournal of medicinal chemistryJune 14, 2012Turrado C, Puig T, García-Cárceles J, Artola M, Benhamú B, Ortega-Gutiérrez S, Relat J, Oliveras G, Blancafort A, Haro D, et al.

Be the First to Write a Review!